Publications
Chimeric antigen receptor T cell therapy (CAR-T cell) - guidelines for costing, counting and reconciliation of funding
The guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults...
Impact of New Health Technology Framework Version 4.4
IHPA recognises the need for the pricing of public hospital services to respond in a timely manner to the introduction of new health technologies and innovations in models of care.
Emergency department care FAQs – Part 1 (Published 25 May 2020)
FAQs to support the classification of COVID-19 in emergency department care.
Mental Health Phase of Care Clinical Refinement Project Final Report
Following the completion of the 2016 Inter-Rater Reliability (IRR) study to test the consistency of clinician application of the mental health phase of care, the poor to fair reliability outcome led to the commencement of the refinement project. The project aims to iden...
Australian National Subacute and Non-Acute Patient Classification Version 4.0 – User Manual – Errata
The list of AN-SNAP V4 classes contained in Appendix 4 included some incorrect class codes in the Admitted Adult Rehabilitation classes. The correct codes (with the incorrect code shown in brackets) are shown in this document
Tier 2 Non-Admitted Services 2019–21
There are three key publications that support the Tier 2 Non-Admitted Services Classification. Tier 2 Non-Admitted Services Definitions Manual, Tier 2 Non-Admitted Services Compendium and Tier 2 Non-Admitted Services National Index.
National Efficient Price Determination 2020–21
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price Determin...
National Efficient Cost Determination 2020–21
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Cost Determina...
National Pricing Model Technical Specifications 2020–21
This document provides the technical specifications for how the Independent Hospital Pricing Authority (IHPA) developed the activity based funding models for the service streams to be funded for the National Efficient Price and the National Efficient Cost Determinations...
Australian Mental Health Care Classification Pricing Feasibility Report 2020–21
The Independent Hospital Pricing Authority (IHPA) has developed the Australian Mental Health Care Classification Pricing Feasibility Report 2020–21 to provide an overview of the process undertaken by IHPA to shadow price admitted mental health services using the Austral...